• OPEN AN ACCOUNT
Indian Indices
Sensex
76,152.86 -417.49
( -0.55%)
Global Indices
Nasdaq
53,087.25 299.37
(0.57%)
Dow Jones
7,688.45 35.98
(0.47%)
Hang Seng
64,337.38 11.74
(0.02%)
Nikkei 225
10,761.93 -27.35
(-0.25%)
Forex
USD-INR
94.95 -0.29
(-0.30%)
EUR-INR
110.11 -0.38
(-0.35%)
GBP-INR
128.48 -0.52
(-0.40%)
JPY-INR
0.59 0.00
(-0.47%)

EQUITY - MARKET SCREENER

Solara Active Pharma Sciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
541540
INE624Z01016
263.3613644
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SOLARA
0
3066.74
EPS(TTM)
Face Value()
Div & Yield %
1.07
10
0
 

hybrid financial services ltd
Gabriel India forms strategic JV with South Korea-based HL Klemove
Aug 26,2026

Gabriel India (GIL) has entered into a strategic joint venture with South Korea-based HL Klemove, under which Gabriel India will become a strategic shareholder in HL Klemove India. The partnership marks a significant step in Gabriel India's strategy to expand its presence across high-growth automotive segments and participate in the growing demand for Autonomous Driving Solutions including Advanced Driver Assistance Systems (ADAS), and Automotive Electronic Products through this joint venture.

Anjali Singh, Executive Chairperson of ANAND Group and Gabriel India, said “Bolstering our position across critical automotive systems while expanding our participation in future-oriented mobility and automotive technology segments, this new JV for Autonomous Driving and Automotive Electronics marks an important inflection point, enabling Gabriel India to further diversify its portfolio and strengthen its participation in emerging mobility segments.”